Loading... Please wait...
Create an account
Therapy Trends Updates
Therapy Area Reports
Alphabetical: A to Z
Alphabetical: Z to A
FirstWord Emerging Markets Reports
Orphan Drug Commercialisation and Market Access in Emerging Markets
Market access for orphan drugs: Can your company break through in emerging markets? Find out which emerging markets offer the best investment prospects for orphan drug manufacturers. Get our new report, Orphan Drug...
Market Access Excellence for Emerging Markets
What knowledge, strategies, and resources do you need right now to maximise your company’s pricing and access in critical emerging markets? With 12 in-depth case studies, Market Access Excellence for Emerging Markets...
Biosimilars in Emerging Markets: Opportunities, Challenges and Critical Success Factors
The biosimilars industry is increasingly focusing its attention on emerging markets, a move that offers both enormous potential and challenges. FirstView’s Biosimilars in Emerging Markets: Opportunities, Challenges...
Inside China’s Pharma Sales Force – insights from the frontline
In 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time. However, very little data is available on China’s sales operations and tactics. FirstWord’s new report sheds light...
Branded Generics: Strategies and Tactics for Winning in Latin America
It’s a $66 billion market—and getting bigger every year. The time is ripe for action. Yet for all the appeal and potential returns of investing in Latin America’s burgeoning branded generics market, there...
Biosimilars in Emerging Markets
There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing a viable global product marketplace is not clear. Biosimilar interest is being driven by the potential...
Driving Brand Value in Emerging Markets -- winning strategies and tactics
Your key to breaking new ground in emerging markets. It’s a case of old versus new: established markets with stagnant, single-digit growth in sales versus double-digit performance in emerging markets. Yet much as the...
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
This comprehensive report goes deep inside China to reveal the ways that recent reforms are changing healthcare for rural and urban citizens. Numerous local experts have been consulted for their insights, including...
Generics as a Vehicle to Improve Market Access
In low and middle-income countries, around 17.6 million people each year die of treatable infectious diseases, reproductive health issues, and childhood illnesses. Millions more experience poor quality of life from chronic...
Branded Generics in South East Asia: Current and Future Opportunities
With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity for Pharma...
Tiered Pricing Strategies in Emerging Markets
For the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: extreme disparities in...
All Contents Copyright © 2017 Doctor's Guide Publishing Limited All Rights Reserved